PURPOSE: Alpha(1)-blockers improve voiding symptoms by decreasing prostatic and urethral smooth muscle tone. However, to our knowledge the mechanism underlying improvements in storage symptoms is not known. Topical application of prostaglandin E(2) to the rat lower urinary tract stimulates the micturition reflex. Using an animal model we investigated whether the alpha(1)-blocker tamsulosin (Astellas Pharma, Tokyo, Japan) acts on C-fiber afferent activity and, if so, the location of this effect. MATERIALS AND METHODS: To induce desensitization of C-fiber afferent activity resiniferatoxin (0.3 mg/kg) was subcutaneously injected in female Sprague-Dawley rats 2 days before experiments. Simultaneous recordings of urethral pressure and rhythmic b...
Dysfunctions of the lower urinary tract, such as overactive bladder syndrome and incontinence, are t...
Purpose: Prostaglandin E-2 and its EP1 receptor were suggested as endogenous modulators of bladder f...
BackgroundTo investigate the effect of a selective P2X3–P2X2/3 purinergic receptor antagonist (A-317...
PURPOSE: Alpha(1)-blockers improve voiding symptoms by decreasing prostatic and urethral smooth musc...
Aims α1-blockers improve voiding symptoms through the reduction of prostatic and urethral smooth mus...
Purpose: Antimuscarinic drugs increase bladder capacity without prominent side effects such as urina...
Purpose: Antimuscarinic drugs increase bladder capacity without prominent side effects such as urina...
Purpose The overactive bladder (OAB) syndrome is characterized by urgency usually with frequency and...
BackgroundTo investigate the effect of a selective P2X3–P2X2/3 purinergic receptor antagonist (A-317...
INTRODUCTION & OBJECTIVES: Following Bladder Outlet Obstruction (BOO) in experimental models, Nerve ...
INTRODUCTION & OBJECTIVES: Following Bladder Outlet Obstruction (BOO) in experimental models, Nerve ...
INTRODUCTION & OBJECTIVES: Following Bladder Outlet Obstruction (BOO) in experimental models, Nerve ...
Purpose Overactive bladder (OAB) causes urinary urgency, usually accompanied by frequency and noctur...
AbstractWe investigated the protective effects of a selective α1A-adrenoceptor antagonist, silodosin...
Purpose Benign prostatic hyperplasia (BPH) impacts quality of life in men by causing lower urinary t...
Dysfunctions of the lower urinary tract, such as overactive bladder syndrome and incontinence, are t...
Purpose: Prostaglandin E-2 and its EP1 receptor were suggested as endogenous modulators of bladder f...
BackgroundTo investigate the effect of a selective P2X3–P2X2/3 purinergic receptor antagonist (A-317...
PURPOSE: Alpha(1)-blockers improve voiding symptoms by decreasing prostatic and urethral smooth musc...
Aims α1-blockers improve voiding symptoms through the reduction of prostatic and urethral smooth mus...
Purpose: Antimuscarinic drugs increase bladder capacity without prominent side effects such as urina...
Purpose: Antimuscarinic drugs increase bladder capacity without prominent side effects such as urina...
Purpose The overactive bladder (OAB) syndrome is characterized by urgency usually with frequency and...
BackgroundTo investigate the effect of a selective P2X3–P2X2/3 purinergic receptor antagonist (A-317...
INTRODUCTION & OBJECTIVES: Following Bladder Outlet Obstruction (BOO) in experimental models, Nerve ...
INTRODUCTION & OBJECTIVES: Following Bladder Outlet Obstruction (BOO) in experimental models, Nerve ...
INTRODUCTION & OBJECTIVES: Following Bladder Outlet Obstruction (BOO) in experimental models, Nerve ...
Purpose Overactive bladder (OAB) causes urinary urgency, usually accompanied by frequency and noctur...
AbstractWe investigated the protective effects of a selective α1A-adrenoceptor antagonist, silodosin...
Purpose Benign prostatic hyperplasia (BPH) impacts quality of life in men by causing lower urinary t...
Dysfunctions of the lower urinary tract, such as overactive bladder syndrome and incontinence, are t...
Purpose: Prostaglandin E-2 and its EP1 receptor were suggested as endogenous modulators of bladder f...
BackgroundTo investigate the effect of a selective P2X3–P2X2/3 purinergic receptor antagonist (A-317...